Key highlights Ozempic (semaglutide) is an FDA-approved GLP-1 medication for type 2 diabetes management, cardiovascular risk reduction, and reducing the risk of worsening kidney disease in patients with chronic kidney disease and type 2 diabetes
Trump has attracted scrutiny for seeing an extraordinary number of specialists as part of the checkup, as well as for an unusual mid-year medical screening he got in October after his annual physical earlier in 2025
compounding pharmacies that are registered with the FDA as facilities, though the compounded products themselves are not FDA-approved
Kahaly GJ, Rosler H-P, Pitz S, Hommel G 2000 Low- versus high-dose radiotherapy for Graves ophthalmopathy: a randomized, single blind trial
Betacarotene, carotenoids, and disease prevention in humans